Credit: Shutterstock

Big am­bi­tions at Mer­ck and As­traZeneca — along with a few gi­ant pit­falls — re­shape top ranks of the R&D 15

Step back from the mul­ti­tude of de­tails that go in­to every big phar­ma pipeline, and you’ll see the in­flu­ence that block­busters have on the en­tire …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.